PARO Assessment: strengths, limits and verdict
AIST / PARO Robots · Specialty
This assessment is based on published specifications and deployment reports, not hands-on testing.

Editorial
PARO remains the clinical benchmark for non-pharmacological dementia intervention, its sensor-driven responsiveness and FDA pedigree delivering measurable reductions in agitation and caregiver burden that few competitors match. Yet the 5-hour runtime and absence of mobility cap its utility to short, supervised sessions rather than autonomous ward coverage. At $6k-plus per unit the economics favor high-volume facilities with existing reimbursement pathways, not broad adoption. Technical stasis since the 8th generation leaves it vulnerable to newer platforms offering longer endurance or multi-patient coordination. Overall it earns its niche but highlights how regulatory strength can outpace mechanical evolution in therapeutic robotics.
What this assessment is based on
Published manufacturer specifications, deployment reports, and operator accounts. ZeroGantry does not claim hands-on testing of this unit unless stated. Judgments are drawn from those public sources — see the methodology for how labels are assigned.
Published 2026-08-17
Pros
- FDA Class II medical device clearance since 2009 enabling institutional reimbursement and hygiene-compliant deployment without live animals
- Five sensor modalities (tactile array with 12+ points, light, audio, temperature, posture) supporting adaptive learning and seal-like vocal responses
- Approximately 5-hour battery runtime per full charge for sustained interaction sessions in care facilities
- Documented deployment across 30+ countries with 40+ peer-reviewed studies showing up to 60% reduction in patient agitation
Cons
- Battery limited to roughly 5 hours necessitating mid-shift recharges and interrupting continuous therapeutic use
- Only 7 motors providing minimal head/leg articulation with no locomotion, confining it to stationary bedside or lap placement
- Unit price of $6,000–$8,000 restricts fleet scaling in budget-constrained dementia care settings
- Antibacterial fur requires specialized sanitization protocols increasing operational overhead in infection-controlled environments
PARO specifications
| Spec | Value | Status | Source |
|---|---|---|---|
| Degrees of freedom | Not published | — | |
| Indicative price | Not published | — |
Not yet verified against a maker source · Overall: Unverified
Other attributes (ZeroGantry classification, not maker-verified)
| Function | Companionship |
|---|---|
| Released | 2004 |
| Maturity | Production |
| Operational status | Active |
How we verify specs: what the status badges mean
- Confirmed Read on the maker's own page, spec sheet, docs or press release as a stated value.
- Claimed Stated by the maker as a target, preliminary figure, “up to” value or performance claim.
- Estimated Derived by us or taken from a third party. Not maker data.
- Unverified No maker primary source checked yet. Treat as unconfirmed.
- Not published The maker does not publish this value.
Every Confirmed, Claimed or Estimated value links to its source and shows the date it was checked. A robot's overall badge reads Confirmed only when every published value is Confirmed, and Partly verified when they are mixed. Read the full methodology.
PARO service and repair
ZeroGantry tracks robot repair and service providers across the United States by state, brand, and robot type.
- Robot repair directory — providers by state, brand, and robot type
Other robot assessments
- Sony aibo (ERS-1000) assessment — Sony
- Hyodol assessment — Hyodol Co.
- temi assessment — temi Inc.
- Unitree H2 assessment — Unitree Robotics
- Booster K1 assessment — Booster Robotics
- Apptronik Apollo 2 assessment — Apptronik